Oxford Cancer Biomarkers announces the EU patent for the use of the biomarker HR23B
Oxford, UK, 07 Sep 2015 Oxford Cancer Biomarkers Ltd (OCB), the UK-based company developing tests that allow medicines to be personalised for the benefit of the cancer patient, has today announced the European Patent Office (EPO) has announced its intention…